![Regulatory & TTS Specialist (Temporary Position) Job at GSK in San Polo I, Emilia-Romagna | Hire Heroes USA Job Board Regulatory & TTS Specialist (Temporary Position) Job at GSK in San Polo I, Emilia-Romagna | Hire Heroes USA Job Board](https://jobboardio.s3.amazonaws.com/uploads/job/logo/189589416/GSK_Heartbeat_Logo.png)
Regulatory & TTS Specialist (Temporary Position) Job at GSK in San Polo I, Emilia-Romagna | Hire Heroes USA Job Board
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW8WDW/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW8WDW.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV
![San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist](https://c8.alamy.com/comp/PW64G3/san-polo-di-torrile-italy-12th-october-2018-gsk-and-viiv-flags-waving-together-in-san-polo-di-torrile-plant-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64G3.jpg)
San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist
![GSK Parma. Accordo sindacale: i dipendenti potranno cedere gratuitamente alcune giornate di ferie ai colleghi che devono assistere un familiare | Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e GSK Parma. Accordo sindacale: i dipendenti potranno cedere gratuitamente alcune giornate di ferie ai colleghi che devono assistere un familiare | Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e](https://www.fedaiisf.it/wp-content/uploads/2018/06/GSK-Parma.png)
GSK Parma. Accordo sindacale: i dipendenti potranno cedere gratuitamente alcune giornate di ferie ai colleghi che devono assistere un familiare | Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e
![San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce](https://c8.alamy.com/comp/PW5TY5/san-polo-di-torrile-italy-12th-october-2018-managers-and-workers-of-gsk-and-italian-authorities-inaugurate-the-new-plant-to-produce-fostemsavir-innovative-drug-for-treatment-resistant-hiv-patients-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW5TY5.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce
![San Polo Di Torrile, Italy - October 12, 2018: Sunight Is Enlightening GSK Logo On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture And Royalty San Polo Di Torrile, Italy - October 12, 2018: Sunight Is Enlightening GSK Logo On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture And Royalty](https://previews.123rf.com/images/gonewiththewind/gonewiththewind1810/gonewiththewind181000578/110218255-san-polo-di-torrile-italy-october-12-2018-sunight-is-enlightening-gsk-logo-on-plant-for-fostemsavir-.jpg)